ICI 182,780 (Fulvestrant™) – the first oestrogen receptor down-regulator – current clinical data

ICI 182,780 (Fulvestrant™) is the first in a new class of novel, steroidal, ’pure‘ antioestrogens – the oestrogen receptor (ER) down-regulators. Its unique mode of action and the absence of partial agonist activity make it a candidate for the treatment of advanced breast cancer in both pre- and post...

Descripción completa

Detalles Bibliográficos
Autor principal: Robertson, J F R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375169/
https://www.ncbi.nlm.nih.gov/pubmed/11900210
http://dx.doi.org/10.1054/bjoc.2001.1982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375169/
https://www.ncbi.nlm.nih.gov/pubmed/11900210
http://dx.doi.org/10.1054/bjoc.2001.1982

Ejemplares similares